Orchard Therapeutics Strongly Supports Enactment of Newborn Metabolic Screening Act in Illinois, Adding Metachromatic Leukodystrophy to Statewide Panel

BOSTON and LONDON, Aug. 02, 2023 -- Orchard Therapeutics , a global gene therapy leader, expresses its strong appreciation for the passage of the Newborn Metabolic Screening Act in Illinois, also...

Related Keywords

Italy ,San Diego ,California ,United States ,Boston ,Massachusetts ,Chicago ,Illinois ,Germany ,Milan ,Lombardia ,London ,City Of ,United Kingdom ,Benjamin Navon ,Barbara Burton ,Leslie Meltzer ,Ann Roberth Lurie ,Mac Graw Hill ,Twitter ,Globenewswire Inc ,San Raffaele Telethon Institute For Gene Therapy ,Centers Of Disease ,Linkedin ,Institute For Genomic Medicine ,Illinois Department Of Public Health Newborn Screening ,Exchange Commission ,Orchard Therapeutics Europe ,Newborn Metabolic Screening Act ,Illinois Department ,Public Health ,Newborn Screening ,Disease Control ,Rady Children ,Genomic Medicine ,Raffaele Telethon Institute ,Gene Therapy ,Securities Act ,Private Securities Litigation Reform Act ,Late Infantile Variant ,Systematic Review ,Child Neurology ,Markets ,